Zhengda Tianqing anti-tumor drug injection with hydrochloric acid benzostin has been issued by the State Drug Administration drug registration approval
-
Last Update: 2020-06-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently, China Bio
Pharmaceutical(http://issued a notice that affiliatedcompany(http://Zhengda Tianqing Pharmaceutical Group, the anti-tumor drug injection with hydrochloric acid benzodiazepine has been issued by the State Drug AdministrationDrug(http://registration approvaltheproduct(http://is in accordance with the new 3 categories of chemical medicine declaration, as if through the quality and efficacy of generic drugs consistent evaluation, but also the first copy approvedBenzostinhydrohydrohydro hydrochloride is a bifunctional baseale inhibitor with anti-tumor and cell-killing effectsGlobal sales of benzodiazepines in 2018 exceeded $600 million, according to MinenetThe announcement mentions that injection of benzodiazepine hydrochloride is suitable for the treatment of rituximaitributicosis or inthe treatment of bonotisxidine regimens during or after treatment of the progression of the disease of inert B cells non-Hodgkin's lymphoma at present, only imported injection with benzodiazepine hydrochloride approved for listing, Zhengda Tianqing Pharmaceutical Group developed the injection of benzodiazepine hydrochloric acid after the listing, will further enrich and improve the group's blood tumor product line layout
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
